Oncotarget
The cover for issue 43 of Oncotarget features Figure 6, "Synergistic effect of carboplatin and ipatasertib in a PDX model of TNBC," by Lin, et al.
Olfactory ensheathing cells travel their natural nasal pathway to deliver therapeutics to brain tumors |
https://doi.org/10.18632/oncotarget.27043 Litia A. Carvalho, and Bakhos A. Tannous |
4351-4353 |
PDF | How to cite | Order a Reprint |
PET-guided treatment in advanced-stage Hodgkin lymphoma: yes but which one? |
https://doi.org/10.18632/oncotarget.27045 Cédric Rossi, and Olivier Casasnovas |
4354-4355 |
PDF | How to cite | Order a Reprint |
Differential gene expression and AKT targeting in triple negative breast cancer |
https://doi.org/10.18632/oncotarget.27026 Feng-Mao Lin, Susan E. Yost, Wei Wen, Paul H. Frankel, Daniel Schmolze, Pei-Guo Chu, Yate-Ching Yuan, Zheng Liu, John Yim, Zhen Chen, and Yuan Yuan |
4356-4368 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Carbon-ion radiotherapy for cholangiocarcinoma: a multi-institutional study by and the Japan carbon-ion radiation oncology study group (J-CROS) |
https://doi.org/10.18632/oncotarget.27028 Goro Kasuya, Kazuki Terashima, Kei Shibuya, Shingo Toyama, Daniel K. Ebner, Hiroshi Tsuji, Tomoaki Okimoto, Tatsuya Ohno, Yoshiyuki Shioyama, Takashi Nakano, Tadashi Kamada, and the Japan Carbon-Ion Radiation Oncology Study Group |
4369-4379 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Photodynamic therapy of cervical cancer by eradication of cervical cancer cells and cervical cancer stem cells |
https://doi.org/10.18632/oncotarget.27029 Elvin Peter Chizenga, Rahul Chandran, and Heidi Abrahamse |
4380-4396 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Cell-free DNA in newly diagnosed patients with glioblastoma – a clinical prospective feasibility study |
https://doi.org/10.18632/oncotarget.27030 Dorte Schou Nørøxe, Olga Østrup, Christina Westmose Yde, Lise Barlebo Ahlborn, Finn Cilius Nielsen, Signe Regner Michaelsen, Vibeke Andrée Larsen, Jane Skjøth-Rasmussen, Jannick Brennum, Petra Hamerlik, Hans Skovgaard Poulsen, and Ulrik Lassen |
4397-4406 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Dicer prevents genome instability in response to replication stress |
https://doi.org/10.18632/oncotarget.27034 Michalis Fragkos, Viviana Barra, Tom Egger, Benoit Bordignon, Delphine Lemacon, Valeria Naim, and Arnaud Coquelle |
4407-4423 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo |
https://doi.org/10.18632/oncotarget.27040 Elgilda Musi, Gary K. Schwartz, Jae Hyuk Yoo, Shannon J. Odelberg, Dean Y. Li, Michael Y. Bonner, Ponniah Selvakumar, Shikha Rao, Linda C. Gilbert, Justin Elsey, and Jack L. Arbiser |
4424-4436 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer |
https://doi.org/10.18632/oncotarget.27055 Laris Achlaug, Rive Sarfstein, Karthik Nagaraj, Lena Lapkina-Gendler, Ilan Bruchim, Manisha Dixit, Zvi Laron, Shoshana Yakar, and Haim Werner |
4437-4448 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Paucimannosidic glycoepitopes inhibit tumorigenic processes in glioblastoma multiforme |
https://doi.org/10.18632/oncotarget.27056 Yvonne Becker, Sarah Förster, Gerrit H. Gielen, Ian Loke, Morten Thaysen-Andersen, Christine Laurini, Kristin Wehrand, Torsten Pietsch, and Simone Diestel |
4449-4465 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Improvement of the rituximab–induced cell death by potentiation of the store-operated calcium entry in mantle cell lymphoma cell lines |
https://doi.org/10.18632/oncotarget.27063 Isabelle Doignon, Olivier Fayol, and Olivier Dellis |
4466-4478 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
CD90low MSCs modulate intratumoral immunity to confer antitumor activity in a mouse model of ovarian cancer |
https://doi.org/10.18632/oncotarget.27065 Yang Zeng, Binghao Li, Tao Li, Wei Liu, Chongzhao Ran, Richard T. Penson, Mark C. Poznansky, Yanan Du, and Huabiao Chen |
4479-4491 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis versus gluten-mediated inhibition in celiac disease |
https://doi.org/10.18632/oncotarget.27037 Luigi Maiuri, Valeria Raia, Mauro Piacentini, Antonella Tosco, Valeria Rachela Villella, and Guido Kroemer |
4492-4500 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Correction: Downregulation of lncRNA MEG3 and miR-770-5p inhibit cell migration and proliferation in Hirschsprung’s disease |
https://doi.org/10.18632/oncotarget.27049 Hongxing Li, Bo Li, Dongmei Zhu, Hua Xie, Chunxia Du, Yankai Xia, and Weibing Tang |
4501-4502 |
Correction | PDF | How to cite |
Correction: RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation |
https://doi.org/10.18632/oncotarget.27066 Susanne V. Schmidt, Stefanie Seibert, Barbara Walch-Rückheim, Benjamin Vicinus, Eva-Maria Kamionka, Jennifer Pahne-Zeppenfeld, Erich-Franz Solomayer, Yoo-Jin Kim, Rainer M. Bohle, and Sigrun Smola |
4503-4504 |
Correction | PDF | How to cite |
Correction: Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency |
https://doi.org/10.18632/oncotarget.27073 Jayaraju Dheekollu, Kimberly Malecka, Andreas Wiedmer, Henri-Jacques Delecluse, Alan K.S. Chiang, Dario C. Altieri, Troy E. Messick, and Paul M. Lieberman |
4505-4506 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC